Abstract

The axon myelin sheath is prone to injury associated with N-methyl-d-aspartate (NMDA)-type glutamate receptor activation but the source of glutamate in this context is unknown. Myelin damage results in permanent action potential loss and severe functional deficit in the white matter of the CNS, for example in ischemic stroke. Here, we show that in rats and mice, ischemic conditions trigger activation of myelinic NMDA receptors incorporating GluN2C/D subunits following release of axonal vesicular glutamate into the peri-axonal space under the myelin sheath. Glial sources of glutamate such as reverse transport did not contribute significantly to this phenomenon. We demonstrate selective myelin uptake and retention of a GluN2C/D NMDA receptor negative allosteric modulator that shields myelin from ischemic injury. The findings potentially support a rational approach toward a low-impact prophylactic therapy to protect patients at risk of stroke and other forms of excitotoxic injury.

Highlights

  • The axon myelin sheath is prone to injury associated with N-methyl-D-aspartate (NMDA)type glutamate receptor activation but the source of glutamate in this context is unknown

  • The results highlight the significance of vesicular glutamate release from axons and demonstrate the involvement of this phenomenon in ischemia-evoked myelin damage

  • The current report is the first to directly measure extracellular glutamate in white matter and while glutamate transport was found to be significant for homeostatic regulation of the neurotransmitter, we found no evidence for significant ischemic release via this mechanism

Read more

Summary

Introduction

The axon myelin sheath is prone to injury associated with N-methyl-D-aspartate (NMDA)type glutamate receptor activation but the source of glutamate in this context is unknown. We show that in rats and mice, ischemic conditions trigger activation of myelinic NMDA receptors incorporating GluN2C/D subunits following release of axonal vesicular glutamate into the peri-axonal space under the myelin sheath. We demonstrate selective myelin uptake and retention of a GluN2C/D NMDA receptor negative allosteric modulator that shields myelin from ischemic injury. GluN2C/D-containing NMDA receptors are generally extra-synaptic while negative allosteric modulators exhibit use-dependent properties. These features suggest that a putative myelinic NMDA receptor/axovesicular glutamate pathway may be amenable to therapeutic intervention with clinical potential

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call